CWM
FATE icon

CIBC World Markets’s Fate Therapeutics FATE Stock Holding History

CIBC World Markets’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$15K Sell
13,400
-8,814
-40% -$10.2K ﹤0.01% 1539
2025
Q1 		$17.6K Buy
+22,214
New +$27.2K ﹤0.01% 1802

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIBC World Markets's FATE Position: Q2 2025 in Review

CIBC World Markets reduced its Fate Therapeutics (FATE) stake by 40% in Q2 2025, selling an estimated $10.2K and leaving 13,400 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

CIBC World Markets first reported a position in FATE in Q1 2025 and has held it in 2 quarters since. The position peaked at $17.6K in Q1 2025. 139 funds tracked by Wall St. Rank hold FATE as of Q2 2025.

  • CIBC World Markets held 13,400 shares of Fate Therapeutics worth $15K as of Q2 2025.
  • CIBC World Markets sold 8,814 Fate Therapeutics shares in Q2 2025, an estimated $10.2K.
  • Fate Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1539 holding.
  • CIBC World Markets first reported a position in Fate Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Fate Therapeutics position peaked at $17.6K in Q1 2025.
  • 139 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.